华西口腔医学杂志 ›› 2019, Vol. 37 ›› Issue (2): 224-228.doi: 10.7518/hxkq.2019.02.017

• 病例报告 • 上一篇    

双膦酸盐相关性颌骨坏死并发腕部舟状骨骨髓炎1例

孙照薇1,李志勇1(),余丹2,朱洁颖1,张伊殿2,朱鑫美1   

  1. 1.浙江大学医学院附属口腔医院口腔颌面外科
    2.浙江大学医学院附属第一医院口腔颌面外科,杭州 310006
  • 收稿日期:2018-06-10 修回日期:2018-11-08 出版日期:2019-04-01 发布日期:2019-04-28
  • 通讯作者: 李志勇 E-mail:hxlzy2002@zju.edu.cn
  • 作者简介:孙照薇,硕士,E-mail: 21618009@zju.edu.cn

Bisphosphonate-related osteonecrosis of the jaw complicated with wrist scaphoid osteomyelitis: a case report

Zhaowei Sun1,Zhiyong Li1(),Dan Yu2,Jieying Zhu1,Yidian Zhang2,Xinmei Zhu1   

  1. 1.Dept. of Oral and Maxillofacial Surgery, Stomatology Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
    2.Dept. of Oral and Maxillofacial Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China
  • Received:2018-06-10 Revised:2018-11-08 Online:2019-04-01 Published:2019-04-28
  • Contact: Zhiyong Li E-mail:hxlzy2002@zju.edu.cn

摘要:

双膦酸盐类药物可以抑制破骨细胞功能,使颌骨骨密度升高,血流减少,发生骨坏死。双膦酸盐类药物相关性骨坏死多发于颌骨。本文报道1例双膦酸盐相关性颌骨坏死并发腕部舟状骨骨髓炎,并结合文献讨论双膦酸盐药物性颌骨坏死的发病机制、治疗与预防等。

关键词: 双膦酸盐, 颌骨坏死, 舟状骨骨髓炎, 唑来膦酸

Abstract:

Bisphosphonates can directly inhibit osteoclasts, which may lead to increased bone density, reduced blood flow, and osteonecrosis of the jaw. Bisphosphonate-related osteonecrosis is usually observed in the jaw bone. In this article, we report a patient with bisphosphonate-related osteonecrosis of the jaw (BRONJ) complicated with wrist scaphoid osteo-myelitis. Furthermore, we introduce the pathogenesis, treatment, and prevention of BRONJ.

Key words: bisphosphonate, osteonecrosis of the jaw, scaphoid osteomyelitis, zoledronic acid

中图分类号: